Last updated 2026-07-26
- Raised $3M Series A led by eHealth Ventures, Jul 2024
- Raised $2.7M grant, Dec 2021
- Raised $1.1M Seed Extension, Dec 2020
Total raised
$16.8M
Last: Undisclosed Round 2024-08
Stage
Seed
Founded
2014
Headcount
20
HQ
Kefar Sava, Israel
Sector
Health Tech & Life Sciences
About
DreaMed Diabetes is an Israeli medical technology company that develops AI-driven solutions for diabetes care and management. The company's flagship product, endo.digital, is a cloud-based SaaS platform that provides personalized recommendations for insulin treatment, aiming to improve outcomes for people with both Type 1 and Type 2 diabetes. The platform processes data from continuous glucose monitors, blood glucose meters, and insulin pumps to offer expert-level care and optimize insulin administration. DreaMed Diabetes was founded out of Schneider Children's Medical Center of Israel in 2014, following seven years developing its artificial pancreas technology.
Funding history · 6 rounds · $16.8M total
2024-07
A Round
$3.0M
★ eHealth Ventures
2021-12
Grant
$2.7M
2020-12
Seed Extension
$1.1M
2016-06
Seed
$4.4M
★ OurCrowd★ Norma Investments
2016-02
Grant
$3.4M
2015-03
Pre-Seed
$2.2M
★ Medtronic
Headcount over time
From 16 (2018-10) to 50 (2026-07) · +34 (+213%) · 22 points · source: Finder history + radar grounding
Q&A
- What is DreaMed Diabetes's primary offering?
- DreaMed Diabetes offers endo.digital, a cloud-based SaaS platform that provides AI-driven personalized recommendations for insulin treatment for both Type 1 and Type 2 diabetes.
- When was DreaMed Diabetes founded?
- DreaMed Diabetes was founded in 2014, emerging from the Schneider Children's Medical Center of Israel.
- What was DreaMed Diabetes's most recent funding round?
- In August 2024, DreaMed Diabetes secured a $3 million A Round, with eHealth Ventures as a lead investor.
- Which organizations have partnered with DreaMed Diabetes for data integration?
- In June 2024, Abbott's FreeStyle Libre data integrated into DreaMed Diabetes's endo.digital platform. Previously, in February 2020, Dexcom announced a collaboration to integrate its CGM data into DreaMed Advisor.
- Has DreaMed Diabetes received FDA clearances for its technology?
- Yes, DreaMed Diabetes received its 5th FDA Clearance in October 2023. Notably, in October 2021, it received FDA clearance for its AI-based clinical decision support system for Type 2 Diabetes.
- How many employees does DreaMed Diabetes currently have?
- DreaMed Diabetes currently has 50 employees, falling within the 11-50 employee bucket.
- Which institutions are deploying DreaMed Diabetes's Advisor system?
- In January 2022, the University of Colorado School of Medicine announced it would work with DreaMed Diabetes to deploy its Advisor System. In May 2024, Yale New Haven Health reported freeing up 9 minutes per patient visit with DreaMed’s EMR integrated deployment.
- What was DreaMed Diabetes's B Round funding in 2020?
- In January 2020, DreaMed Diabetes raised $7 million in a B Round, with Medtronic.
Team · 8
Eran Atlas
Founder · Co-Founder & CEO
Prof. Moshe Phillip
Founder · Co-Founder, Chairman and Chief Scientist
Prof. Revital Nimri
Founder · Co-Founder & Chief Medical R&D
Ido Muller
Founder · Co-Founder & Algo/Data Director
Aviel Fogel
Founder · Founder
Shahar Miller
Founder · Founder
Tadej Battelino
Founder · Co-Founder
Thomas Danne
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportMedical DevicesMedical Treatment & Therapeutics
Technologies
Data StorageCloudArtificial IntelligenceSensing
Target customers
Healthcare & Life SciencesHealthcareInsurance CompaniesProvidersPatients
Business model
B2B2CB2B
Highlights
1 PatentsVerified
Tags
digital-healthcaremonitoringdiabetesdata-analyticsremote-monitoringdecision-makingreal-timetelemedicinehealthcare-providerssensorscloudactionable-insightstelehealthartificial-intelligencechronic-patientspersonalizationtreatmentsinsurance-companiesdecision-support
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | dreamed.ai/ |
|---|---|
| linkedin.com/company/5220173 | |
| facebook.com/pages/DreaMed-Diabetes/686958088038870 | |
| YouTube | youtube.com/channel/UC7atXxpifFgbyfRMzm5CTKw/?sub_confirmati |
Identifiers & details
| Legal name | DreaMed Diabetes Ltd. |
|---|---|
| Founded | 2014 |
| Employees (exact) | 20 |
Radar intelligence
Patents
| EPO | 5 |
|---|
GitHub
| Top repos | uploader-stg-releases, node-data-tools, uploader-qa-releases, uploader-clinical-releases, uploader-releases |
|---|
Web history (Wayback)
| Domain | dreamed.ai |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515052520 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2014-03-09 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 4 — shares_capital (2), people (2) |
| Registered address | קפלן אליעזר 14 פתח תקווה |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-15 | הקצאת מניות |
| 2026-04-12 | העברת מניות |
| 2026-03-10 | עדכון דירקטורים-הוספת דירקטור |
| 2026-03-10 | עדכון דירקטורים-הסרת דירקטור |